Evidence map›Paper›PMID 27822469›Full record

ArticleBioMed research international2016

Xiao-Xiao Lu, Lan-Yu Cao, Xi Chen, Jian Xiao, Yong Zou, Qiong Chen

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. HPV-Independent Cervical Cancer-A New Challenge of Modern Oncology.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Enhanced Anti-Cancer Potential: Investigating the Combined Effects withInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Lactucin, a Bitter Sesquiterpene fromMolecules (Basel, Switzerland) · 2022
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiao-Xiao LuDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.ORCID 0000-0001-8972-431X
Lan-Yu CaoDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.
Xi ChenDepartment of Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.
Jian XiaoDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.
Yong ZouDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.
Qiong ChenDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.ORCID 0000-0002-2534-8834
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ApoptosisCell Cycle CheckpointsDown-RegulationGene Expression Regulation, NeoplasticSignal TransductionAdenocarcinomaAmino Acid SubstitutionCell Line, TumorChromonesHumansLung NeoplasmsMorpholinesMutation, MissensePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN Phosphohydrolase2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesMorpholinesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanTelomeraseTERT protein, human

Identifiers

PMID27822469
PMCPMC5086351
OpenAlexW2531150801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.